MMCM
MDT icon

Murphy & Mullick Capital Management’s Medtronic MDT Stock Holding History

Murphy & Mullick Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.4K Buy
778
+3
+0.4% +$287 0.05% 250
2025
Q4 		$74.4K Buy
775
+1
+0.1% +$97 0.05% 229
2025
Q3 		$70.4K Buy
774
+8
+1% +$735 0.05% 236
2025
Q2 		$66.8K Sell
766
-43
-5% -$3.65K 0.05% 234
2025
Q1 		$72.7K Buy
809
+4
+0.5% +$358 0.07% 215
2024
Q4 		$64.7K Buy
+805
New +$69.7K 0.06% 226

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Murphy & Mullick Capital Management's MDT Position: Q1 2026 in Review

Murphy & Mullick Capital Management increased its Medtronic (MDT) stake by 0.39% in Q1 2026, buying an estimated $287 and bringing the position to 778 shares worth $67.4K. The position accounts for 0.05% of the portfolio, ranked #250.

Murphy & Mullick Capital Management first reported a position in MDT in Q4 2024 and has held it in 6 quarters since. The position peaked at $74.4K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Murphy & Mullick Capital Management held 778 shares of Medtronic worth $67.4K as of Q1 2026.
  • Murphy & Mullick Capital Management bought 3 Medtronic shares in Q1 2026, an estimated $287.
  • Medtronic made up 0.05% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #250 holding.
  • Murphy & Mullick Capital Management first reported a position in Medtronic in Q4 2024 and has held it in 6 quarters since.
  • Murphy & Mullick Capital Management's Medtronic position peaked at $74.4K in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.